The angiotensin II AT1 receptor antagonist irbesartan prevents thromboxane A2-induced vasoconstriction in the rat hind-limb vascular bed in vivo

Journal of Hypertension

Volumn 19, Issue 3 SUPPL., 2001, Pages 561-566

  Fukuhara, M ^a   Neves, L A ^a   Li, P ^a   Diz, D I ^a   Ferrario, C M ^a   Brosnihan, K B ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin II; AT1 receptor antagonist; Hind limb perfusion; Rat; Regional vascular resistance; Thromboxane A2

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; CANDESARTAN; IRBESARTAN; PHENYLEPHRINE; PROSTAGLANDIN ENDOPEROXIDE; THIOBUTABARBITAL; THROMBOXANE A2; U 46659; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; BENZIMIDAZOLE DERIVATIVE; BIPHENYL DERIVATIVE; TETRAZOLE DERIVATIVE; THROMBOXANE RECEPTOR; VASOCONSTRICTOR AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ATTENUATION; BLOOD FLOW; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; HINDLIMB; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION; ANIMAL; ARTICLE; BLOOD VESSEL; DRUG EFFECT; DRUG POTENTIATION; SPRAGUE DAWLEY RAT; VASCULARIZATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; BLOOD VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; HINDLIMB; MALE; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RECEPTORS, THROMBOXANE; TETRAZOLES; VASCULAR RESISTANCE; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0035072743     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200103001-00007     Document Type: Conference Paper

References (16)

1. 2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats
2. 2-induced contractions in canine coronary arteries
3. 2-induced vasoconstriction in canine coronary arteries and human platelet aggregation
4. 2 (TP) receptors
5. 2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist
6. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats
7. Pharmacological profile of a highly potent and long acting angiotensin II receptor antagonist
8. 1 subtype angiotensin II receptor antagonist
9. Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension
10. 1 receptor antagonist in hypertensive rat models
11. Nonpeptide angiotensin II receptor antagonists: The next generation in antihypertensive therapy
12. Interactions of non-peptide angiotensin II receptor antagonists at imidazoline/guanidinium receptor sites in rat forebrain
13. The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism
14. 3H)losartan in the rat liver
15. A reivew of mutagenesis studies of angiotensin II type 1 receptor, the three-dimensional receptor model in search of the antagonist binding site and the hypothesis of a receptor activation mechanism
16. Identification of amino acid residues of rat angiotensin II receptor for ligand binding by site directed mutagenesis